Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

765 ARTÍCULOS , VIENDO DEL 31 AL 45

Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease

Vance JM, Farrer LA, Huang Y, Cruchaga C, Hyman BT, Pericak-Vance MA, Goate AM, Greicius MD, Griswold AJ, Haines JL, Tcw J, Schellenberg GD, Tsai LH, Herz J, Holtzman DM.

Ann Neurol. 2024 Apr;95(4):625-634. doi: 10.1002/ana.26864. Epub 2024 Jan 5.

The function of sphingolipids in different pathogenesis of Alzheimer's disease: A comprehensive review

Wang X, Li H, Sheng Y, He B, Liu Z, Li W, Yu S, Wang J, Zhang Y, Chen J, Qin L, Meng X.

Biomed Pharmacother. 2024 Feb;171:116071. doi: 10.1016/j.biopha.2023.116071. Epub 2024 Jan 6.

How promising are the latest monoclonal antibodies targeting amyloid-β for the treatment of early Alzheimer's disease?

Beveridge J, Kaniecki E, Naidu A, Silverglate BD, Grossberg G.

Expert Opin Emerg Drugs. 2024 Mar;29(1):35-43. doi: 10.1080/14728214.2024.2304059. Epub 2024 Jan 12.

Agents at the Peak of US FDA Approval for the Treatment of Alzheimer's Disease

Alam J, Kalash A, Hassan MI, Rahman SZ.

Neurol Res. 2024 Apr;46(4):318-325. doi: 10.1080/01616412.2024.2302271. Epub 2024 Jan 10.

Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer's Disease

Drakontaeidi A, Pontiki E.

Int J Mol Sci. 2024 Jan 1;25(1):582. doi: 10.3390/ijms25010582.

Passive immunotherapy for Alzheimer's disease

Guo X, Yan L, Zhang D, Zhao Y.

Ageing Res Rev. 2024 Feb;94:102192. doi: 10.1016/j.arr.2024.102192. Epub 2024 Jan 14.

Antioxidant, anti-inflammatory and epigenetic potential of curcumin in Alzheimer's disease

Abdul-Rahman T, Awuah WA, Mikhailova T, Kalmanovich J, Mehta A, Ng JC, Coghlan MA, Zivcevska M, Tedeschi AJ, de Oliveira EC, Kumar A, Cantu-Herrera E, Lyndin M, Sikora K, Alexiou A, Bilgrami AL, Al-Ghamdi KM, Perveen A, Papadakis M, Ashraf GM.

Biofactors. 2024 Jul-Aug;50(4):693-708. doi: 10.1002/biof.2039. Epub 2024 Jan 16.

Alzheimer's disease, aging, and cannabidiol treatment: a promising path to promote brain health and delay aging

Liu Y.

Mol Biol Rep. 2024 Jan 16;51(1):121. doi: 10.1007/s11033-023-09162-1.

TREM2 in Alzheimer's disease: Structure, function, therapeutic prospects, and activation challenges

Zgorzynska E.

Mol Cell Neurosci. 2024 Mar;128:103917. doi: 10.1016/j.mcn.2024.103917. Epub 2024 Jan 19.

Talking With Patients About the New Anti-amyloid Alzheimer Disease Medications

Sarkisian CA, Romanov A, Mafi JN.

Ann Intern Med. 2024 Feb;177(2):246-248. doi: 10.7326/M23-3377. Epub 2024 Jan 23.

Immunotherapy in Alzheimer's Disease: From the Bench to the Bedside

Diniz BS.

Am J Geriatr Psychiatry. 2024 May;32(5):584-585. doi: 10.1016/j.jagp.2024.01.013. Epub 2024 Jan 14.

Mapping racial and ethnic healthcare disparities for persons living with dementia: A scoping review

Hinton L, Tran D, Peak K, Meyer OL, Quiñones AR.

Alzheimers Dement. 2024 Apr;20(4):3000-3020. doi: 10.1002/alz.13612. Epub 2024 Jan 24.

Current Advances and Future Perspectives on Mesenchymal Stem Cell-Derived Extracellular Vesicles in Alzheimer's Disease

Zhang W, Uyemura R, Zhong K, Guo R, Zhong L.

Aging Dis. 2024 Oct 1;15(5):2015-2027. doi: 10.14336/AD.2023.1206.

Understanding the mechanisms of disease modifying effects of aerobic exercise in people with Alzheimer's disease

Abdullahi A, Wong TW, Ng SS.

Ageing Res Rev. 2024 Feb;94:102202. doi: 10.1016/j.arr.2024.102202. Epub 2024 Jan 23.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias